Africa's genome is not for sale

Africa’s genetic diversity is being exploited for global health and scientific research, with critics warning of a new form of bio-colonialism. While projects like the $1.6 billion health data agreement between Kenya and the U.S. are framed as advancing medical progress, concerns persist over data anonymization and informed consent. A *Science* study revealed that even anonymized DNA can be linked to individuals using public genealogy databases, exposing the fragility of privacy protections. The *African Genome Variation Project*, published in *Nature*, highlights Africa’s unparalleled genetic diversity, making its populations prime targets for data extraction. However, without strong sovereign safeguards, anonymization fails as a true shield, leaving communities vulnerable to surveillance and exploitation. Legal ambiguities over data ownership—whether belonging to individuals, communities, or states—further complicate ethical oversight, particularly in rural areas where consent may be coerced or poorly understood. Beyond healthcare, genetic data risks enabling discriminatory practices, such as insurance companies or employers using biological risk scores to exclude individuals. Historical abuses, like Pfizer’s 1996 Kano trial where children were tested without proper consent, underscore the ethical dangers of unregulated research. Today, digital extraction replaces physical experimentation, embedding inequality into algorithms that dictate life outcomes based on genetic predispositions. Kenya’s defense of its health data agreements relied on anonymization claims, but advances in AI now allow identities to be reconstructed from fragmented genetic data. Once digitized, genetic information cannot be altered, making it a permanent tool for surveillance—potentially implicating entire family lineages. The lack of clear international laws on data ownership exacerbates exploitation, as corporations and governments operate in a legal vacuum. Critics argue that genetic data collection disproportionately targets African populations, despite Western societies reaping the majority of benefits. Without robust protections, the continent risks becoming a resource for global science while facing the consequences of algorithmic apartheid—where genetic markers determine access to jobs, insurance, or justice. The *African Genome Variation Project* warns that without sovereignty over data, Africa’s biological legacy could be weaponized against its own people.